Iterum TherapeuticsITRMF
13F holders, Q4 2025 (December 31)16holders −4
2new positions
7sold out
$0.33avg. 13F price*
At the end of Q4 2025, 16 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, down 4 from Q3 2025. 2 opened new positions and 7 sold out. The largest holders were Apollon Financial, LLC ($211K), Jane Street Group, LLC ($97K) and Alchemi Wealth, LLC ($90K).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7K |
| Exits | 7 | $495K |
All 13F filers, Q3 2025 → Q4 2025: 786,757 shares bought and 770,441 shares sold, net +16,316 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Apollon Financial, LLC | 0.03% | Add +151.8% | 630,250 | $211K |
| Jane Street Group, LLC | 0.00% | Add +1893.5% | 289,410 | $97K |
| Alchemi Wealth, LLC | 0.05% | — | 268,886 | $90K |
| UBS Group AG | 0.00% | Add +1290.5% | 119,948 | $40K |
| Krilogy Financial LLC | 0.00% | No change | 40,000 | $13K |
| Virtu Financial LLC | 0.00% | Reduce -53.2% | 22,062 | $7K |
| Ground Swell Capital, LLC | 0.01% | New | 20,477 | $7K |
| Sanctuary Advisors, LLC | 0.00% | No change | 20,000 | $7K |
| Geode Capital Management, LLC | 0.00% | No change | 12,370 | $4K |
| SG Americas Securities, LLC | 0.00% | Reduce -24.0% | 12,782 | $4K |
| Morgan Stanley | 0.00% | Reduce -33.7% | 5,713 | $2K |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 1,680 | $563 |
| Activest Wealth Management | 0.00% | No change | 133 | $45 |
| Wells Fargo & Company | 0.00% | No change | 85 | $28 |
| Robinswood Financial LLC | 0.00% | New | 66 | $22 |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $5 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.